Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00360932 · ClinicalTrials.gov registry record
Facial Lipoatrophy Correction Experience With SCULPTRA ("FACES" Study)
A clinical trial, sponsored by Bausch Health Americas.
- Completed
- Registry status
- 290
- Enrollment target
NCT00360932 is a clinical trial that has completed, run by Bausch Health Americas. The registered enrollment target is 290 participants.
The verdict
NCT00360932 has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- 290 participants
- Enrollment target
Study Summary
5 year, open-label study to evaluate safety of SCULPTRA on the signs of lipoatrophy of the face in at least 100 evaluable subjects with human immunodeficiency virus.
Interventions
- DEVICE SCULPTRA (poly-L-lactic acid injection)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 290 participants |
| Start Date | 2005-10 |
| Est. Completion | 2011-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00360932
The ClinicalTrials.gov registry entry for NCT00360932 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 290 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch Health Americas, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SCULPTRA (poly-L-lactic acid injection) is the first listed.
NCT00360932 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00360932 about?
NCT00360932 is a clinical study titled "Facial Lipoatrophy Correction Experience With SCULPTRA ("FACES" Study)". 5 year, open-label study to evaluate safety of SCULPTRA on the signs of lipoatrophy of the face in at least 100 evaluable subjects with human immunodeficiency virus.
What is the current status of trial NCT00360932?
This trial is currently completed. The enrollment target is 290 participants. The study started on 2005-10. Estimated completion is 2011-08.
What interventions are being tested in trial NCT00360932?
The interventions under investigation include: SCULPTRA (poly-L-lactic acid injection) (DEVICE).
Who is sponsoring clinical trial NCT00360932?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.